Merian Life Sciences ApS: Financial statements 2022
CVR: 40288589
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Merian Life Sciences ApS (CVR 40288589) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 595,585 and a net result of DKK 433,053 compared with DKK 290,280 the year before. That is an increase of 51% compared with the year before. Equity in the 2022 report amounted to DKK 1,249,021. The solvency ratio was 89.1%.
- Gross Profit
- DKK 595,585
- Profit/Loss
- DKK 433,053
- Equity
- DKK 1,249,021
- Total Assets
- DKK 1,402,235
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 596K | 433K | 1.2M | 0 |
| 2021 | - | 394K | 290K | 930K | 0 |
| 2020 | - | 457K | 334K | 619K | 0 |
| 2019 | - | 345K | 234K | 284K | 1 |
Official annual report
Keep an eye on Merian Life Sciences ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Merian Life Sciences ApS has published its annual report for 2021. Gross profit came to DKK 394,441, and the net result was DKK 290,280.
About Merian Life Sciences ApS
Merian Life Sciences ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Menachem and Neil Goldsmith. The company is owned by Birgitte Menachem and Neil Goldsmith. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 280,804 and a net result of DKK -36,911 compared with DKK 835,491 the year before. Equity in the 2025 report amounted to DKK 2,002,914.